It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Over the 15 years since the decoding of the human genome a large number of individual genomes have been sequenced. Targeted sequencing - sequencing of select genome regions - has been widely used both in research and in medical practice. The use of various types of genetic analysis is starting to be used in daily clinical routine. At the same time, the price of sequencing decreases and as a result, the amount of genetic information available to researchers and physicians increases. These processes together determine the need for creation of databases for the centralized storage of genetic information which is crucial for synchronization and validation of the work of various institutions. One of the first such databases was the NCBI database created and supervised by the US National Center for Biotechnological Information (NCBI) in collaboration with the National Institute for Human Genome Research (NHGRI). At the same time, the available methods for studying associations between DNA polymorphisms and various phenotypic manifestations do not cover the most important layer of regulation of biological processes - the proteome. The methods of high-throughput proteomic analysis that are to be developed will allow identifying driver mutations that make the greatest contribution to the phenotype of the studied object. The application of an integrated analysis of the genome and proteome for the diagnosis and treatment of cancer pathologies is one of the most important research goals now. This approach will allow to identify new genetic biomarkers that could be used for reliable prediction of the treatment response, risks of the most important diseases, and the development of novel medications. This review shows recent advances in proteomic and genomic approaches to the development of more sensitive diagnostic and prognostic biomarkers that can be translated into improved clinical care and treatment of the disease.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Voronezh State University, Voronezh, Russian Federation